home / stock / aclx / aclx quote
Last: | $53.29 |
---|---|
Change Percent: | -0.54% |
Open: | $52.46 |
Close: | $53.29 |
High: | $54.05 |
Low: | $51.32 |
Volume: | 291,538 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$53.29 | $52.46 | $53.29 | $54.05 | $51.32 | 291,538 | 05-02-2024 |
$52.18 | $50.27 | $52.18 | $53.97 | $50.19 | 542,054 | 05-01-2024 |
$50.02 | $50.62 | $50.02 | $51.595 | $49.808 | 500,347 | 04-30-2024 |
$51.11 | $52.08 | $51.11 | $52.45 | $50.59 | 388,007 | 04-29-2024 |
$51.92 | $51.35 | $51.92 | $52.68 | $50.87 | 339,688 | 04-26-2024 |
$51.38 | $51.52 | $51.38 | $51.965 | $49.66 | 631,751 | 04-25-2024 |
$52.82 | $54.54 | $52.82 | $54.94 | $52.54 | 301,155 | 04-24-2024 |
$54.44 | $52.25 | $54.44 | $55.94 | $52.25 | 408,982 | 04-23-2024 |
$52 | $52.28 | $52 | $53.35 | $50.54 | 438,388 | 04-22-2024 |
$51.65 | $54.23 | $51.65 | $55.12 | $51.03 | 742,730 | 04-19-2024 |
$54.5 | $53.24 | $54.5 | $54.89 | $52.59 | 692,182 | 04-18-2024 |
$53.55 | $55.87 | $53.55 | $55.87 | $53.25 | 472,430 | 04-17-2024 |
$55.22 | $56.34 | $55.22 | $56.75 | $54.8 | 747,629 | 04-16-2024 |
$56.96 | $58.08 | $56.96 | $59.14 | $56.87 | 381,994 | 04-15-2024 |
$58.07 | $59.73 | $58.07 | $59.8 | $57.55 | 496,250 | 04-12-2024 |
$60.17 | $59.54 | $60.17 | $60.51 | $59.22 | 326,594 | 04-11-2024 |
$59.08 | $58.9 | $59.08 | $60.29 | $58.51 | 521,314 | 04-10-2024 |
$60.56 | $60.6 | $60.56 | $61.32 | $59.42 | 489,982 | 04-09-2024 |
$60.7 | $62.8 | $60.7 | $62.8 | $60.245 | 407,301 | 04-08-2024 |
$62.22 | $62.33 | $62.22 | $63.965 | $61.12 | 319,403 | 04-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Arcellx Inc. Company Name:
ACLX Stock Symbol:
NASDAQ Market:
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the 23rd Annual Needham Virtual Health...
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the H.C. Wainwright 2nd Annual Cell Th...
Morgan Stanley initiates Arcellx Inc (NASDAQ:ACLX), noting a differentiated CAR-T platform for blood cancer backed by an established...